Advertisement
Screener

Ionis Pharmaceuticals, Inc. (IONS) ROA

IONIS PHARMACEUTICALS INC ROA

Return on assets (ROA) is the profit a company earns for every dollar of assets it uses, shown as a percentage. It is net income divided by total assets, and the table shows both amounts. Because assets are funded by lenders as well as shareholders, ROA is not inflated by borrowing the way ROE can be, and it is naturally lower for businesses that need many factories, stores or other assets. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • IONIS PHARMACEUTICALS INC roa for the quarter ending 2026-06-30 was -18.87%, a change of -9.89% year-over-year.
  • IONIS PHARMACEUTICALS INC roa for the quarter ending 2026-03-31 was -9.48%, a change of 6.81% year-over-year.
  • IONIS PHARMACEUTICALS INC roa for the quarter ending 2025-12-31 was -10.82%, a change of 4.29% year-over-year.
  • IONIS PHARMACEUTICALS INC roa for the quarter ending 2025-09-30 was -8.45%, a change of 3.19% year-over-year.
  • IONIS PHARMACEUTICALS INC roa for fiscal 2025 was -10.82%, a change of 4.29% from fiscal 2024.
  • IONIS PHARMACEUTICALS INC roa for fiscal 2024 was -15.11%, a change of -2.86% from fiscal 2023.
  • IONIS PHARMACEUTICALS INC roa for fiscal 2023 was -12.25%, a change of -1.61% from fiscal 2022.
  • IONIS PHARMACEUTICALS INC roa for fiscal 2022 was -10.64%, a change of -9.55% from fiscal 2021.
Available history
2009-12-31 to 2026-06-30
Data captured

Historical ROA

DateROANet income 12 monthNet income 3 monthTotal assets
2026-06-30-18.87%-$565.17M-$114.65M$2.99B
2026-03-31-9.48%-$326.98M-$92.53M$3.45B
2025-12-31-10.82%-$381.39M-$229.39M$3.52B
2025-09-30-8.45%-$256.34M-$128.61M$3.03B
2025-06-30-8.99%-$268.22M$123.55M$2.99B
2025-03-31-16.28%-$458.03M-$146.94M$2.81B
2024-12-31-15.11%-$453.9M-$104.35M$3B
2024-09-30-11.65%-$358.81M-$140.48M$3.08B
2024-06-30-13.59%-$365.74M-$66.27M$2.69B
2024-03-31-13.92%-$384.77M-$142.80M$2.76B
2023-12-31-12.25%-$366.29M-$9.26M$2.99B
2023-09-30-13.96%-$409.45M-$147.41M$2.93B
2023-06-30-10.40%-$309.04M-$85.29M$2.97B
2023-03-31-11.40%-$328.88M-$124.32M$2.89B
2022-12-31-10.64%-$269.72M-$52.43M$2.53B
2022-09-300.30%$7.32M-$46.99M$2.42B
2022-06-30-1.15%-$28.15M-$105.14M$2.46B
2022-03-31-0.15%-$3.89M-$65.17M$2.52B
2021-12-31-1.09%-$28.6M$224.61M$2.61B
2021-09-30-25.17%-$607.74M-$82.47M$2.41B
2021-06-30-22.02%-$549.74M-$80.88M$2.5B
2021-03-31-21.99%-$494.5M-$89.87M$2.25B
2020-12-31-18.59%-$444.26M-$354.53M$2.39B
2020-09-302.54%$78.68M-$24.47M$3.1B
2020-06-304.20%$129.31M-$25.64M$3.08B
2020-03-314.98%$154.07M-$39.63M$3.09B
2019-12-318.60%$278.14M$184.41M$3.23B
2019-09-3014.85%$429.81M$26.16M$2.89B
2019-06-3013.87%$399.08M-$876.00K$2.88B
2019-03-3112.68%$359.61M$84.44M$2.84B
2018-12-3110.26%$273.74M$320.08M$2.67B
2018-09-30-2.19%-$49.25M-$4.56M$2.25B
2018-06-30-2.11%-$47.31M-$40.36M$2.25B
2018-03-31-0.77%-$10.04M-$1.42M$1.3B
2017-12-310.03%$348,000.00-$2.92M$1.32B
2017-09-304.41%$55.29M-$2.61M$1.25B
2017-06-305.98%$65.25M-$3.08M$1.09B
2017-03-311.06%$11.48M$8.96M$1.08B
2016-12-31-6.62%-$60.4M$25.86M$912.47M
2016-09-30-21.79%-$183.85M$7.35M$843.59M
2016-06-30-27.98%-$226.98M-$56.85M$811.11M
2016-03-31-15.35%-$134.48M-$62.92M$875.82M
2015-12-31-9.31%-$88.28M-$71.43M$947.9M
2015-09-301.44%$14.21M-$35.78M$988.01M
2015-06-302.39%$23.31M$35.65M$976.26M
2015-03-31-2.56%-$24.42M-$16.72M$955.43M
2011-06-30-12.15%-$64.32M-$17.89M$529.57M
2011-03-31-14.15%-$71.59M-$19.99M$505.94M
2010-12-31-11.13%-$61.25M-$13.99M$550.48M
2010-09-30-11.13%-$64.11M-$12.45M$575.86M
2010-06-30-10.43%-$63.23M-$25.15M$606.35M

Annual ROA

DateROANet income 12 monthTotal assets
2025-12-31-10.82%-$381.39M$3.52B
2024-12-31-15.11%-$453.9M$3B
2023-12-31-12.25%-$366.29M$2.99B
2022-12-31-10.64%-$269.72M$2.53B
2021-12-31-1.09%-$28.6M$2.61B
2020-12-31-18.59%-$444.26M$2.39B
2019-12-318.60%$278.14M$3.23B
2018-12-3110.26%$273.74M$2.67B
2017-12-310.03%$346,000.00$1.32B
2016-12-31-6.62%-$60.4M$912.47M
2015-12-31-9.31%-$88.28M$947.9M
2014-12-31-4.08%-$38.98M$955.81M
2013-12-31-7.16%-$60.64M$847.16M
2010-12-31-11.13%-$61.25M$550.48M
2009-12-3123.60%$155.07M$657.18M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Spyre Therapeutics, Inc. (SYRE)United States$7.685B-43.69
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41
Alkermes plc. (ALKS)$6.844B132.74
RHYTHM PHARMACEUTICALS, INC. (RYTM)United States$6.771B-37.20
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60
Liquidia Corp (LQDA)United States$6.347B51.23
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10